ArticleJournal of diabetes and metabolic disorders2017
Association of serum complement C3 with metabolic syndrome components in normal weight obese women.
Article in Journal of diabetes and metabolic disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis.International journal of obesity (2005) · 2021Pooled it
- Obesity and clinical outcomes in COVID-19 patients without comorbidities, aFrontiers in endocrinology · 2022Trial
- Blood Serum From Obese Women Raises ROS Production by Neural Stem Cells.Developmental neurobiology · 2026Article
- Complement C3 in panvascular disease: a central integrator of immune signaling and vascular remodeling.Clinical science (London, England : 1979) · 2025Review
- Sociodemographic and Health Determinants of Adipose Tissue Distribution in a Local Community from Eastern Poland: A Cross-Sectional Study.Journal of clinical medicine · 2025Article
- Normal Weight Obesity Overview and Update: A narrative review.Current obesity reports · 2025Review
- Machine Learning Model in Obesity to Predict Weight Loss One Year after Bariatric Surgery: A Pilot Study.Biomedicines · 2024Article
- What can patients tell us in Sjögren's syndrome?Rheumatology and immunology research · 2024Review
- Obesity Contributes to Inflammation in Patients with IBS via Complement Component 3 and C-Reactive Protein.Nutrients · 2022Article
- Increased trunk fat is associated with altered gene expression in breast tissue of normal weight women.NPJ breast cancer · 2022Article
- Article
- Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review.Journal of diabetes and metabolic disorders · 2021Review
- MALDI-TOF MS Characterisation of the Serum Proteomic Profile in Insulin-Resistant Normal-Weight Individuals.Nutrients · 2021Article
- Normal weight obesity and unaddressed cardiometabolic health risk-a narrative review.International journal of obesity (2005) · 2021Review
- Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review.Cancer prevention research (Philadelphia, Pa.) · 2021Review
- Signal Transducer and Activator of Transcription 3 (STAT3) Suppresses STAT1/Interferon Signaling Pathway and Inflammation in Senescent Preadipocytes.Antioxidants (Basel, Switzerland) · 2021Article
- Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).Diabetes/metabolism research and reviews · 2021Review
- Physical Fitness but Not Diet Quality Distinguishes Lean and Normal Weight Obese Adults.Journal of the Academy of Nutrition and Dietetics · 2020Article
- Inverse association between periumbilical fat and longevity mediated by complement C3 and cardiac structure.Aging · 2020Article
- The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy.Journal of clinical medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIncreased serum complement C3 has been related to body fat mass, metabolic syndrome and chronic diseases. The purpose of this study was to evaluate the levels of C3 in the subjects of normal weight obese (hereafter NWO) as well as their possible relationships with metabolic syndrome and inflammation.
methodsIn this case-control study, 40 obese women with normal weight (body mass index (BMI) = 18.5-24.9 kg/m
resultsMean waist and hip circumferences in NWO was higher than non-NWO (74.78 ± 4.81 versus 70.76 ± 2.91 and 99.12 ± 4.32 versus 93.16 ± 2/91, respectively,
conclusionObese women with normal body mass index but high body fat percentage have higher serum C3 and are at a higher risk for metabolic dysregulation and metabolic syndrome than the healthy non-obese subjects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.